Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Endometrial%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
/vufind/Search/Results?lookfor=%22Endometrial%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
Search /vufind/Search2/Results?lookfor=%22Endometrial%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
PubPharm (28.164)
1
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors : Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone : A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma : A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients With Deficient Mismatch Repair System Recurrent Endometrial Carcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial : A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial : Molecular Analysis for Combination Therapy Choice (ComboMATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer : A Phase II, Single-Arm Study of Giredestrant in Patients With Grade 1 Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer : Department of Obstetrics & Gynecology ,Peking University People's Hospital
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer : A Phase 2 Exploratory, Multicenter, Open-Label Trial to Determine the Safety and Preliminary Clinical Activity of GEN1046 in Combination With Anticancer Agents in Subjects With Advanced Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer : Phase I/II Trial of Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer (EC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2817]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
28.142
Aufsätze
23.937
E-Ressourcen
23.922
E-Artikel
4.220
Gedruckte Aufsätze
22
Bücher
15
E-Books
11
Hochschulschriften
7
Gedruckte Bücher
Alle anzeigen ...
weniger ...
Zeitschriftentitel
1.460
WHO International Clinical Trials Registry Plat...
1.222
ClinicalTrials.gov
1.199
Archives of gynecology and obstetrics
911
Gynecologic oncology
568
Inpharma weekly
414
Reactions weekly
406
BMC cancer
390
Cancers
341
Journal of cancer research and clinical oncology
287
Gynecological surgery
275
Frontiers in oncology
273
Reproductive sciences
251
Reproductive biology and endocrinology
241
Journal of assisted reproduction and genetics
236
International journal of gynecological cancer :...
234
Annals of surgical oncology
208
The journal of obstetrics and gynaecology research
205
Cancer causes & control
204
International journal of molecular sciences
203
Journal of gynecologic oncology
Alle anzeigen ...
weniger ...
Thema
12.700
Journal Article
6.001
Endometrial cancer
3.792
endometrial cancer
2.682
610
2.357
Research Support, Non-U.S. Gov't
2.158
Study Type: Interventional
2.140
Endometrial Cancer
1.861
Review
1.347
Endometrial carcinoma
1.266
Endometrial Neoplasms
861
Case Reports
827
Biology
818
endometrial carcinoma
812
Endometrium
790
Physiology
697
Recruitment Status: Recruiting
689
Family Planning
685
Biomarkers, Tumor
678
Uterus
645
Contraception
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
12.112
2020-
12.223
2010-2019
1.292
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26.722
Englisch
616
Chinesisch
365
Deutsch
149
Französisch
130
Russisch
98
Spanisch
55
Ukrainisch
36
Italienisch
35
Portugiesisch
26
Persisch
25
Polnisch
20
Türkisch
16
Tschechisch
16
Unbestimmt
15
Koreanisch
10
Niederländisch
6
Ungarisch
6
Japanisch
6
Schwedisch
5
Bulgarisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...